(PLXS) Plexus - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US7291321005
PLXS: Electronic, Medical, Industrial, Aerospace, Defense, Communication Devices
Plexus Corp, a leading provider of electronic manufacturing services, operates globally, offering a comprehensive range of solutions to its clients. The company's services encompass design, development, supply chain management, new product introduction, and manufacturing, in addition to sustaining services that ensure the long-term viability of its clients' products. By providing these services, Plexus Corp enables its clients to focus on their core competencies, such as research and development, while outsourcing the manufacturing and logistics aspects to a trusted partner.
The company's client base spans multiple market sectors, including aerospace and defense, where it supports the production of complex systems and equipment; healthcare and life sciences, where it manufactures medical devices and equipment; industrial and commercial, where it produces a range of products, from industrial control systems to commercial electronics; and communications, where it supports the development of networking and telecommunications equipment. This diversification allows Plexus Corp to mitigate risks associated with dependence on a single industry and to capitalize on growth opportunities across various sectors.
Founded in 1979, Plexus Corp has established itself as a reliable and innovative partner for companies seeking electronic manufacturing services. Headquartered in Neenah, Wisconsin, the company has expanded its operations globally, with a presence in the United States and internationally. Its website, https://www.plexus.com, provides detailed information on its services, capabilities, and client success stories. As a publicly traded company, listed on the NASDAQ stock exchange under the ticker symbol PLXS, Plexus Corp is committed to transparency and accountability, with its common stock (ISIN: US7291321005) classified under the GICS Sub Industry: Electronic Manufacturing Services.
Additional Sources for PLXS Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PLXS Stock Overview
Market Cap in USD | 4,277m |
Sector | Technology |
Industry | Electronic Components |
GiC Sub-Industry | Electronic Manufacturing Services |
IPO / Inception | 1986-02-05 |
PLXS Stock Ratings
Growth 5y | 77.7% |
Fundamental | 35.9% |
Dividend | - |
Rel. Strength Industry | 296 |
Analysts | 3.67/5 |
Fair Price Momentum | 186.44 USD |
Fair Price DCF | 325.99 USD |
PLXS Dividends
No Dividends PaidPLXS Growth Ratios
Growth Correlation 3m | 54.5% |
Growth Correlation 12m | 95.5% |
Growth Correlation 5y | 84.9% |
CAGR 5y | 15.77% |
CAGR/Mean DD 5y | 1.42 |
Sharpe Ratio 12m | 1.75 |
Alpha | 43.69 |
Beta | 1.05 |
Volatility | 27.67% |
Current Volume | 159.3k |
Average Volume 20d | 202.9k |
As of January 21, 2025, the stock is trading at USD 167.36 with a total of 159,259 shares traded.
Over the past week, the price has changed by +3.31%, over one month by +5.21%, over three months by +22.85% and over the past year by +68.29%.
Partly, yes. Based on ValueRay Fundamental Analyses, Plexus (NASDAQ:PLXS) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 35.89 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PLXS as of January 2025 is 186.44. This means that PLXS is currently undervalued and has a potential upside of +11.4% (Margin of Safety).
Plexus has received a consensus analysts rating of 3.67. Therefor, it is recommend to hold PLXS.
- Strong Buy: 1
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, PLXS Plexus will be worth about 207 in January 2026. The stock is currently trading at 167.36. This means that the stock has a potential upside of +23.71%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 153.2 | -8.5% |
Analysts Target Price | 153.2 | -8.5% |
ValueRay Target Price | 207 | 23.7% |